<didl:DIDL xmlns:didl="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dip="urn:mpeg:mpeg21:2002:01-DIP-NS" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd urn:mpeg:mpeg21:2005:01-DIP-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dip/dip.xsd" DIDLDocumentId="https://arxiv.universalpublishings.com/id/eprint/80917">
  <didl:Item>
    <didl:Descriptor>
      <didl:Statement mimeType="application/xml">
        <dii:Identifier>https://arxiv.universalpublishings.com/id/eprint/80917</dii:Identifier>
      </didl:Statement>
    </didl:Descriptor>
    <didl:Descriptor>
      <didl:Statement mimeType="application/xml">
        <dcterms:modified>2026-05-26T16:13:48Z</dcterms:modified>
      </didl:Statement>
    </didl:Descriptor>
    <didl:Component>
      <didl:Resource mimeType="application/xml" ref="https://arxiv.universalpublishings.com/cgi/export/eprint/80917/DIDL/arxiv-eprint-80917.xml"/>
    </didl:Component>
    <didl:Item>
      <didl:Descriptor>
        <didl:Statement mimeType="application/xml">
          <dip:ObjectType>info:eu-repo/semantics/descriptiveMetadata</dip:ObjectType>
        </didl:Statement>
      </didl:Descriptor>
      <didl:Component>
        <didl:Resource mimeType="application/xml">
          <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
        <dc:relation>https://arxiv.universalpublishings.com/id/eprint/80917/</dc:relation>
        <dc:title>SEROPREVALENCE OF TOXOCARA SPP AMONG EPILEPTIC PATIENTS IN IRAQ/BASRA</dc:title>
        <dc:creator>Sabbar, Ban Anas</dc:creator>
        <dc:creator>Assim, Assim Khalid</dc:creator>
        <dc:creator>Mahdi, Nadham Kadham</dc:creator>
        <dc:description>To study&amp;nbsp; seroprevalence of Toxocara&amp;nbsp; antibody Immunoglobulin G (IgG) and epidemiological risk factors as well as assessment&amp;nbsp; the immunological pattern including cytokines, interleukin-6&amp;nbsp; (IL6) and&amp;nbsp; interleukin-10 (IL-10) and immunoglobulin E (IgE) among epileptic patients in Basra province . Subjects and Methods: Forty seven epileptic patients, their ages range from 2.5 - 45 years (22 females and 25 males)&amp;nbsp; and 109 apparently healthy volunteers&amp;nbsp; as&amp;nbsp; a control group with ages range between 2 - 80 years (59 females and 50 males ) were enrolled in this study. The study was done during the period from&amp;nbsp; December 2017 to November 2018 at&amp;nbsp;&amp;nbsp;&amp;nbsp; The Pediatric and Neurology Consulting Clinic&amp;nbsp;&amp;nbsp; of Basra Teaching Hospital. The risk and epidemiologic factors&amp;nbsp; were&amp;nbsp; assessed&amp;nbsp;&amp;nbsp; by&amp;nbsp; a special questionnaire&amp;nbsp; which&amp;nbsp;&amp;nbsp;&amp;nbsp; was&amp;nbsp; completed&amp;nbsp;&amp;nbsp; by&amp;nbsp; the patients&amp;nbsp; themselves&amp;nbsp;&amp;nbsp;&amp;nbsp; or&amp;nbsp;&amp;nbsp; their&amp;nbsp;&amp;nbsp; relative. Immunoglobulin G (IgG) and cytokines were assessed by using ELISA while IgE by immunoturbidimetric&amp;nbsp;&amp;nbsp;&amp;nbsp; assay by&amp;nbsp; using the Abbott ARCHITECT c System for every epileptic patient as well as control group. Results: Sixteen (34.04%)&amp;nbsp; of epileptic patients were seropositive for Toxocara antibody (IgG ) in comparison with 2 (1.83%) of control group with significant difference between them (p=0.0001). There was no significant association between seropositive&amp;nbsp;&amp;nbsp; and seronegative epileptic patients in regard to characteristic features of the studied population (sex and age) and risk factors (residence, exposure to soil,&amp;nbsp; animal ownership, presence of home garden, onychophagia, thumb sucking, medicine intake, family history, duration of epilepsy&amp;nbsp; and occupation) except geophagia . But interestingly, there were&amp;nbsp;&amp;nbsp; elevated in risk ratio&amp;nbsp; for 5 variables&amp;nbsp;&amp;nbsp;&amp;nbsp; including onychophagia (1.7), thumb sucking (2.1), geophagia (3.4), medication intake (1.1) and family history (1.7), when it is evaluated by Chi-squared “Fisher exact test” (risk ratio &amp;gt;1). The immunological assessments&amp;nbsp; reveal an elevation IgE and IL-10 level in seropositive group in comparison seronegative group&amp;nbsp; without a significant difference, while IL-6&amp;nbsp; concentration is elevated in theseronegative group.&amp;nbsp; Conclusion: In epileptic patients in Basra province, infection with Toxocara spp may play role as&amp;nbsp; a risk factor for idiopathic epilepsy. Risk factors such as onychophagia,&amp;nbsp; geophagia, thumb sucking, medication intake and family history may increase risk infection with Toxocara spp in epileptic patients. Also toxocariasis may&amp;nbsp; lead to elevation of&amp;nbsp; IgE and IL-10 levels in these patients but it appears has a weak influence on concentration of IL-6.</dc:description>
        <dc:publisher>Research Science and Innovation house</dc:publisher>
        <dc:date>2024-04-02</dc:date>
        <dc:type>Maqola</dc:type>
        <dc:type>NonPeerReviewed</dc:type>
        <dc:identifier>  Sabbar, Ban Anas, Assim, Assim Khalid, Mahdi, Nadham Kadham  (2024) SEROPREVALENCE OF TOXOCARA SPP AMONG EPILEPTIC PATIENTS IN IRAQ/BASRA.  MEDICINE, PEDAGOGY AND TECHNOLOGY: THEORY AND PRACTICE.       </dc:identifier>
        <dc:relation>https://universalpublishings.com/index.php/mpttp/article/view/4982</dc:relation>
        <dc:relation>oai:ojs.pkp.sfu.ca:article/4982</dc:relation>
        <dc:identifier>oai:ojs.pkp.sfu.ca:article/4982</dc:identifier></oai_dc:dc>
        </didl:Resource>
      </didl:Component>
    </didl:Item>
    <didl:Item>
      <didl:Descriptor>
        <didl:Statement mimeType="application/xml">
          <dip:ObjectType>info:eu-repo/semantics/humanStartPage</dip:ObjectType>
        </didl:Statement>
      </didl:Descriptor>
      <didl:Component>
        <didl:Resource ref="https://arxiv.universalpublishings.com/id/eprint/80917/" mimeType="application/html"/>
      </didl:Component>
    </didl:Item>
  </didl:Item>
</didl:DIDL>